Janssen Research and Development
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
2019 · Vlado Perkovic, Meg Jardine, et al. · New England Journal of Medicine
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
2015 · Charles J. Ryan, Matthew R. Smith, et al. · The Lancet Oncology
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
2019 · Kim N., Neeraj Agarwal, et al. · New England Journal of Medicine